To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Part 1: This is a 5 Arm study primarily to determine the best dose out of the two dose levels of Belinostat and Pralatrexate combined with CHOP/COP in newly diagnosed PTCL patients based on Safety for part 2 study. Part 2 (Efficacy and Safety): This is a 3 Arm study. Patients with previously untreated PTCL will be randomized 1:1:1 into 1 of 3 treatment groups: 2 experimental treatment groups (Bel-CHOP or Fol-COP) or 1 active comparator treatment group (CHOP). Patients will be treated for up to 6 cycles. The primary objective is to compare the Progression Free Survival of patients with newly diagnosed PTCL treated for up to 6 cycles with Beleodaq (belinostat) in combination with CHOP (Bel-CHOP) or Folotyn (pralatrexate injection) in combination with COP (Fol-COP) to CHOP alone.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Nowo rozpoznany, nielechony chłoniak T-komórkowy potwierdzony badaniem histologicznego
- •Dostępny materiał do badania patologicznego przed włączeniem do badania
- •Co najmniej jedno widoczne ognisko choroby dające się zmierzyć
- •Dobry stan ogólny (możliwość wykonywania codziennych czynności)
- •Prawidłowe wyniki badań krwi, wątroby i nerek
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 22, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (69)
University of California, San Francisco Fresno
Clovis, United States
University of California, Los Angeles Hem/ Onc Clinical Research Unit, Suite 600
Santa Monica, United States
University of Colorado School of Medicine
Aurora, United States
Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System Memorial Cancer Institute
Pembroke Pines, United States
Norton Cancer Institute
Louisville, United States
Henry Ford Health System
Detroit, United States
Rutgers Cancer Institute of New Jersey
New Brunswick, United States
Valley Cancer Associates
Harlingen, United States
Houston Methodist Hospital
Houston, United States
University of Texas, MD Anderson Cancer Center
Houston, United States
Baylor Scott & White Medical Center - Temple
Temple, United States
The Ottawa Hospital
Ottawa, Canada
Princess Margaret Hospital
Toronto, Canada
Universitatsmedizin Gottingen
Göttingen, Germany
Universitaetsklinikum Halle (Saale)
Halle, Germany
University of Debrecen Clinical Center
Debrecen, Hungary
Andras Josa University Teaching Hospital
Nyíregyháza, Hungary
Semmelweis Egyetem
Budapest, Hungary
National Institute of Oncology
Budapest, Hungary
Markhot Ferenc Oktato Korhaz
Eger, Hungary
Belgyogyaszati Klinika es Kardiologiai Kozpont
Szeged, Hungary
Azienda Ospedaliera Cardinale Giovanni Panico
Tricase, Italy
University of Milano Bicocca
Milan, Italy
Servizio Sanitario Regionale Emilia-Romagna-Istituto Scientifico Romagnolo per lo Studio dei Tumori "Dino Amadori" Srl (IRST)
Meldola, Italy
Policlinico GB Rossi Borgo Roma
Borgo Roma, Italy
Azienda Ospedaliera SS. Antonio e Biagio e C. Arrigo
Alessandria, Italy
Ospedale Policlinico San Martino, IRCCS
Genova, Italy
Azienda Ospedaliera Universitaria di Parma
Parma, Italy
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy
Azienda USL di Ravenna
Ravenna, Italy
University Hospital in Wroclaw
Wroclaw, Poland
Pratia MCM Krakow
Krakow, Poland
Narodowy Instytut Onkologii im Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy
Warsaw, Poland
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi
Lodz, Poland
Inje University Busan Paik Hospital
Busan, South Korea
Ulsan University Hospital
Ulsan, South Korea
Ajou University Hospital
Suwon, South Korea
The Catholic University of Korea - St. Vincents Hospital
Suwon, South Korea
Gyeongsang National University Hospital
Jinju, South Korea
Jeonbuk National University Hospital
Jeonju, South Korea
Yeungnam University Medical Center
Daegu, South Korea
Severance hospital, Yonsei University
Sinchon-dong, South Korea
Asan Medical Center
Songpa-dong, South Korea
Daegu Catholic University Medical Center
Daegu, South Korea
Gachon University Gil Medical Center
Incheon, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Hospital Universitario Basurto
Bilbao, Spain
Hospital Universitario Fundación Jiménez Díaz
Moncloa-Aravaca, Spain
Hospital Universitario de Navarra
Pamplona, Spain
Hospital del Mar Medical Research Institute
Barcelona, Spain
ICO - Hospital Duran i Reynals
Barcelona, Spain
Clinica Universidad de Navarra - Madrid
Madrid, Spain
Clinica Universidad de Navarra
Pamplona, Spain
Hospital Universitario de Salamanca
Salamanca, Spain
Hospital Universitario y Politecnico La Fe
Valencia, Spain
Hospital Universitario Miguel Servet
Zaragoza, Spain
Changhua Christian Hospital CCH
Changhua, Taiwan
Hualien Tzu Chi Medical Center
Hualien City, Taiwan
National Cheng Kung University Hospital NCKUH
Tainan, Taiwan
Chang Bing Show Chwan Memorial Hospital
Changhua, Taiwan
Hematology Oncology Taipei Medical University - Shuang-Ho Hospital
New Taipei City, Taiwan
Chang Gung Memorial Hospital Linkou Branch
Taoyuan, Taiwan
Ankara University Medical Faculty Hospital
Altındağ, Turkey (Türkiye)
Bilkent University
Çankaya, Turkey (Türkiye)
Gazi University Faculty of Medicine
Yenimahalle, Turkey (Türkiye)
VKV AMERICAN HOSPITAL, Medical Oncology Outpatient Clinic
Şişli, Turkey (Türkiye)
Adana City Education and Research Hospital
Adana, Turkey (Türkiye)
Ege Univ. Hospital
Bornova, Turkey (Türkiye)
Trial contact
Uma Srinivas Atmuri, MPharm, MS
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/23/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.